How much revenue does Neurobiological Technologies make?

Neurobiological Technologies reported $26.35 million in revenue for fiscal year 2009, up 78.5% from $14.76 million in fiscal year 2008. In Q1 2010 revenue was $6.03 million.

What companies are similar to Neurobiological Technologies?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include YourWay Cannabis Brands Inc. (YOURF), Australis Capital Inc. (AUSAF), Corix Bioscience, Inc. (CXBS), TetraLogic Pharmaceuticals Corporation (TLOG).

Neurobiological Technologies, Inc. (NTII) Stock

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.

At a glance

Neurobiological Technologies reported revenue of $26.35 million for fiscal year 2009, up 78.5% from fiscal year 2008, and net income of $3.12 million. In Q1 2010 (the quarter ended September 30, 2009) revenue was $6.03 million, up 69.0% from a year before.

Figures from company filings; latest fiscal year ended June 30, 2009.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.